Epidemiology and genetics of psoriasis;Épidémiologie et génétique du psoriasis

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 8-9 II, 2003, Pages 829-836

  Dereure, O ^a   Guilhou, J J ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

CHROMOSOME 6; DISEASE TRANSMISSION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; PSORIASIS; REVIEW; RISK FACTOR; ANIMAL; DISEASE MODEL; GENETICS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; PSORIASIS;

EID: 0142024084     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Lomholt G. Psoriasis: prevalence, spontaneous course and genetics. Copenhagen, Denmark: GEC GAD; 1963.
2. Hellgren L. Psoriasis. Stockholm, Sweden: Almqvist & Wiksell; 1967.
3. Bandrup F, Green A. Prevalence of psoriasis in Denmark. Acta Derm Venereologica 1981;61:344-6.
4. Braathen LR, Botten G, Bjerkedal T. Prevalence of psoriasis in Norway. Acta Derm Venereologica 1989;142:5-8.
5. Dewerdt S, Vaillant L, Malvy D. Evaluation de la prévalence du psoriasis en France. Ann Dermatol Venereol 1997;124:92S.
6. bis. Cribier B, Guillot B, Cambazard F, et al. Patient perception of psoriasis: a survey based on a representative sample of the French population. I. Demographic data and general concepts concerning the disease. Ann Dermatol Vénéréol 2002;129:1S752.
7. Bell LM, Sedlack R, Beard CM, Perry HO, Michet CJ, Kurland LT. Incidence of psoriasis in Rochester, Minn 1980-1983. Arch Dermatol 1991;127:1184-7.
8. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974;148:1-18.
9. Smith AE, Kassab JY, Rowland Payne CME, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 1993;186:181-6.
10. Swanbeck G, Inerot A, Martisson T, Wahlstrom J, Enerback C, Enlund F, et al. Age at onset and different types of psoriasis. Br J Dermatol 1995;133:768-73.
11. Hecht H. Psoriasis und Vererbung. Arch Derm Syph Berl 1930;160:49-51.
12. Swanbeck G, Inerot A, Martisson T, Enerback C, Enlund F, Samuelsson L, et al. Genetic counselling in psoriasis: empirical data on psoriasis among first-degree relatives of 3,095 psoriasis probands. Br J Dermatol 1997;137:939-42.
13. Bandrup F, Holm N, Grunnet N, Henningsen K, Hansen HE. Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm Venereol 1982;62:229-36.
14. Duffy DL, Spelman LS, Martin NG. Psoriasis in Australian twins. J Am Acad Dermatol 1993;29:428-34.
15. Farber EM, Nall ML, Watson W. Natural history of psoriasis in 61 twin pairs. Arch Dermatol 1974;109:207-11.
16. Bandrup F. Psoriasis in first-degree relatives of psoriatic twins. Acta Derm Venereol 1984;64:220-6.
17. Christophers E, Henseler T. Patients subgroups and the inflammatory pattern in psoriasis. Acta Derm Venereol 1989;69:88-92.
18. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-6.
19. Naldi L, Tognoni G, Cainelli T. Analytic epidemiology in psoriasis. J Invest Dermatol 1994;102:19S-23S.
20. Kruger G, Duvic Madeleine. Epidemiology of psoriasis. Clinical issues. J Invest Dermatol 1994;102:14S-18S.
21. O'Doherty CJ, McIntyre C. Palmoplantar pustulosis and smoking. BMJ 1985;291:861-4.
22. Naldi L, Parazzini F, Brevi A, Peserico A, Veller Fornasa C, Grosso G, Rossi E, Marinaro P, Polenghi MM, Finzi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992;127:212-7.
23. Duvic M. Immunology of AIDS related to psoriasis. J Invest Dermatol 1990;95:38s-40s.
24. Abel EA, DiCicco LM, Orenberg EK, Fraki JE, Farber EM. Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986;15:1007-22.
25. Abele D, Dobson R, Graham J. Heredity and psoriasis. Study of a large family. Arch Dermatol 1963;88:38-47.
26. Watson W, Cann HM, Farber EM, Nall ML. The genetics of psoriasis. Arch Dermatol 1972;105:197-207.
27. Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ. Arch Dermatol 1994;130:216-24.
28. Henseler T. The genetics of psoriasis. J Am Acad Dermatol 1997;37: S1-11.
29. Elder JT, Nair RP, Henseler T, Jenisch R, Stuart P, Chia N, et al. The genetics of psoriasis 2001. The odyssey continues. Arch Dermatol 2001;137:1447-54.
30. Risch N. Linkage strategies for genetically complex traits. I: multilocus models. Am J Hum Genet 1990;46:222-8.
31. Ananthakrishnan R, Eckes L, walter H. On the genetics of psoriasis: an analysis of Lomholt's data from Faroe Islands for a multifactorial mode of inheritance. J Genet 1974;61:142-50.
32. Theeuwes M, Morhenn V. Allelic instability in the mitosis model and the inheritance of psoriasis. J Am Acad Dermatol 1995;32:44-52.
33. Russell TJ, Schultes LM, Kuban DJ. Histocompatibility (HLA) antigens associated with psoriasis. N Engl J Med 1972;287:738-43.
34. Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M. Psoriasis and HLA CW6. Br J Dermatol 1980;102:179-84.
35. Henseler T, Koch F, Westphal E, Nair RP, Voorhees JJ, Elder JJ, et al. Presence of HLA-DR7 in type 1 psoriasis. J Invest Dermatol 1992;98:607.
36. Mallon E, Newson R, Bunker CB. HLA-CW6 and the genetic predisposition to psoriasis: a meta-analysis of published serologic studies. J Invest Dermatol 1999;113:693-4.
37. Mallon E, Bunce M, Wojnarowska F, Welsh K. HLA-CW*0602 is a susceptibility factor in type I psoriasis and evidence Ala-73 is increased in male type I psoriasis. J Invest Dermatol 1997;109:183-6.
38. Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R, et al. HLA-CW*0602 and HIV-associated psoriasis. Br J Dermatol 1998;139:527-33.
39. Asahina A, Akazaki S, Nakagawa H, Kuwata S, Tokunaga K, Ishibashi Y, et al. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J Invest Dermatol 1991;97:254-8.
40. Brazzelli V, Quaglini M, Martinetti M, Nolli G, Salvaneschi L, Cuccia M, et al. A peculiar sequence motif in the alpha-1 domain of the HLA-C molecule in psoriasis. Dermatology 2000;200:99-103.
41. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two-stage genome-wide search in psoriasis. Hum Mol Genet 1997;6:813-20.
42. Capon F, Munro M, Barker J, Trembath. Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol 2002;118:745-51.
43. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, et al. Gene for familial susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-5.
44. Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) ant two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997;6:1349-56.
45. Matthews D, Fry L, Powles A, Weber J, McCarthy M, Fisher E, et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nature genet 1996;14:231-3.
46. Capon F, Novelli G, Semprini S, Clementi M, Nudo M, Vultaggio P, et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1998;112:32-5.
47. Veal CD, Clough RL, Barber RC, Mason S, Tillman D, Ferry B, et al. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet 2001;38:7-13.
48. Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB, et al. Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 1999;113:322-8.
49. Oka A, Tamiya G, Tomizawa M, Ota M, Katsuyama Y, Makino S, et al. Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111kb-segment telomeric to the HLA-C gene. Hum Mol Genet 1999;8:2165-70.
50. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, et al. Localization of psoriasis susceptibility locus PSORS1 to a 60 kilobase interval telomeric to HLA-C. Am J Med Genet 2000;66:1833-44.
51. Guerrin M, Simon M, Montezin M, Haftek M, Vincent C, Serre G. Expression cloning of human corneodesmosin proves its identity with the product of the S gene and allows improved characterization of its processing during keratinocyte differentiation. J Biol Chem 1998;273:22640-7.
52. Jenisch S, Koch S, Henseler T, Nair RP, Elder JT, Watts CE, et al. Corneodesmosin gene polymorphism demonstrates strong linkage disequilibrium with HLA and association with psoriasis vulgaris. Tissue Antigens 1999;54:439-49.
53. Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, Suomela S, Snellman E, et al. A candidate gene for psoriasis near HLA-C, HCR (Pg8) is highly polymorphic with a disease-associated susceptibility allele. Hum Mol Genet 2000;9:1533-42.
54. Chia NV, Stuart P, Nair RP, Henseler T, Jenisch S, Lim HW, et al. Variations in the HCR (Pg8) gene are unlikely to be causal for familial psoriasis. J Invest Dermatol 2001;116:823-4.
55. Gonzalez S, Martinez-Borra J, Del Rio JS, Santos-Juanes J, Lopez-Vazquez A, Blanco-Gelaz M, et al. The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J Invest Dermatol 2000;115:824-8.
56. Teraoka Y, Naruse TK, Oka A, Matsuzawa Y, Shiina T, Iizuka M, et al. Genetic polymorphisms in the cell growth regulated gene, SC1 telomeric of the HLA-C gene and lack of association of psoriasis vulgaris. Tissue Antigens 2000;55:206-11.
57. Gonzalez S, Brautbar C, Martinez-Borra J, Lopez-Vazquez A, Segal R, Blanco-Gelaz MA, et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 2001;62:632-8.
58. Choi HB, Han H, Youn JI, Kim TY, Kim TG. MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population. Tissue Antigens 2000;56:548-50.
59. Schön M. Animal models of psoriasis-What can we learn from them? J Invest Dermatol 1999;112:405-10.
60. Beamer WG, Pelsue SC, Shultz LD, Sundberg JP, Barker JE. The flaky skin (fsn) mutation in mice: map location and description of the anemia. Blood 1995;86:3220-6.
61. Carroll JM, Romero MR, Watt FM. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995;83:957-68.
62. Leonard JM, Abramczuk JW, Pezen DS, Rutleger R, Belcher JH, Hakim F, Shearer G, Lampreth L, Travis W, Frederickson T, Notkins AL, Martin MA. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 1988;242:1665-70.
63. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay GS. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988;335:606-12.
64. Chen CL, Yull FE, Cardwell N, Singh N, Strayhorn WD, Nanney LB, et al. RAG2-/-, IKB-α-/- chimeras display a psoriasiform skin disease. J Invest Dermatol 2000;115:1124-33.